SCHEMBL548628

SCHEMBL548628

[O-][S+](c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
CYP2A6 P11509 1/20 0.50
MAPK1 P28482 3/20 0.39
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 1/20 0.39
IDO1 P14902 2/20 0.38
CA1 P00915 5/20 0.36
CA2 P00918 5/20 0.36
CA12 O43570 2/20 0.36
CA3 P07451 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA5A P35218 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA13 Q8N1Q1 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
TSHR P16473 4/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9635796 1.00 LMNA (0.50) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL9637022 1.00 LMNA (0.50) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL9637222 0.92 CYP1A2 (0.48) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL197577 0.92 CYP1A2 (0.48) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL197578 0.89 TSHR (0.48) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL7937426 0.87 MAPT (0.41) LMNACYP2A6ALDH1A1TSHRCYP1A2
SCHEMBL10923598 0.87 MEN1 (0.50) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL28881835 0.87 CES2 (0.45) LMNACYP2A6CES1CES2MEN1
SCHEMBL9635825 0.87 CYP2A6 (0.38) LMNACYP2A6MAPK1CYP3A4ALDH1A1
SCHEMBL7935399 0.87 MAPK1 (0.46) LMNACYP2A6MAPK1CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 962 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079841-A Synthesis method of tris (p-tolyl) sulfonium hexafluorophosphate 2026-05-26 CN claimed
US-12583882-B2 Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates MIRECA MEDICINES GMBH (DE) 2026-03-24 US claimed
EP-4598504-A2 MICROPARTICLE AND IMPLANT FORMULATIONS FOR CGMP ANALOG THERAPY Mireca Medicines GmbH (DE) 2025-08-13 EP claimed
US-12168642-B2 Process for producing 4,4′-dichlorodiphenyl sulfoxide BASF SE (DE) 2024-12-17 US claimed
CN-118546407-A High-wear-resistance ultraviolet-resistant film and preparation method thereof 海安浩驰科技有限公司 2024-08-27 CN claimed
EP-4021889-B1 A PROCESS FOR OBTAINING 4,4'-DICHLORODIPHENYL SULFONE BASF SE (DE) 2024-06-26 EP claimed
CN-118024701-B Preparation method of sheet, scratch-resistant hot-bending sheet and application of sheet in clothing 汕头市亮彩新材料科技有限公司 2024-06-07 CN claimed
CN-118024701-A Preparation method of sheet, scratch-resistant hot-bending sheet and application of sheet in clothing 汕头市亮彩新材料科技有限公司 2024-05-14 CN claimed
CN-117946154-A Organic silicon resin monomer containing large steric hindrance functional group, preparation method thereof and application of high-temperature-resistant material 哈尔滨工业大学 2024-04-30 CN claimed
WO-2024074585-A2 MICROPARTICLE AND IMPLANT FORMULATIONS FOR cGMP ANALOG THERAPY MIRECA MEDICINES GMBH (DE) 2024-04-11 WO claimed
EP-0514835-B1 Elastomers and products having reduced hysteresis properties BRIDGESTONE CORP (JP) 1996-07-17 EP claimed
EP-0306051-B1 Process for production of aromatic polyethers MITSUBISHI GAS CHEMICAL CO (JP) 1996-03-06 EP claimed
EP-0514835-A1 Elastomers and products having reduced hysteresis properties BRIDGESTONE CORPORATION (JP) 1992-11-25 EP claimed
US-5151469-A Curing an anionic polymer in the presence of a catalyst BRIDGESTONE CORPORATION (JP) 1992-09-29 US claimed
US-5144004-A Heat resistance, selective degradation, reaction of halogen substituted sulfones and sulfoxides and alkali metal sulfides PHILLIPS PETROLEUM COMPANY (US) 1992-09-01 US claimed
US-4952665-A Process for production of aromatic polyethers with alkali metal carbonate/bicarbonate/fluoride cocatalyst MITSUBISHI GAS CHEMICAL COMPANY, LTD. (JP) 1990-08-28 US claimed
EP-0306051-A1 Process for production of aromatic polyethers MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1989-03-08 EP claimed
US-4734465-A POLYHYDROXY VULCANIZATION AGENT; AMINOPHOSPHINIC ACCELERATOR; METAL OXIDE, HYDROXIDE OR CARBONATE ACID ACCEPTOR; AND A PHOSPHATE, AMINOPHOSPHATE, SULFONE OR SULFOXIDE MONTEDISON S.P.A. (IT) 1988-03-29 US claimed
US-4438282-A REDUCTION OF SULFOXIDE WITH HYDRAZINE OR HYDROXYLAMINE OR DERIVATIVE BASF AKTIENGESELLSCHAFT (DE) 1984-03-20 US claimed
US-4122021-A PHENYLATED NAPHTHALAMINES, SULFOXIDES UNIROYAL, INC. (US) 1978-10-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583882-B2 Equatorially modified polymer linked multimers of guansine-3′, 5′-cyclic monophosphates PDE7A, PRKG1, NT5C3B LMNA 2067/4885CYP2A6 4146/4885MAPK1 1242/4885
US-12168642-B2 Process for producing 4,4′-dichlorodiphenyl sulfoxide HSPA4L, CLIC4, ATG4A LMNA 4710/4885CYP2A6 809/4885MAPK1 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.